marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Oramed Pharmaceuticals Financial Ratios 2011-2024 | ORMP
Annual Financial Ratios Oramed Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
21.1 | -2.3 | -20.8 | -5.3 | -3.9 | -5.7 | -12.6 | -8.4 | -8.2 | -13.2 | -10.6 | -6.8 | -14.6 |
P/S |
86.9 | 31.5 | 94.4 | 22.4 | 20.6 | 29.6 | 53.8 | 143.0 | - | - | - | - | - |
EPS |
0.1 | -0.9 | 0.8 | 0.6 | 0.8 | 0.9 | 0.8 | 0.9 | 0.7 | 0.6 | 0.6 | 0.6 | -0.0 |
EV (Enterprise Value) |
107 M | 44.6 M | 228 M | 53 M | 67.6 M | 83.8 M | 148 M | 104 M | 57.5 M | 74.4 M | 43 M | 19.7 M | 21.8 M |
EBITDA per Share |
-0.39 | -1.04 | -0.85 | -0.506 | -0.838 | -0.909 | -0.809 | -0.793 | -0.682 | -0.638 | -0.596 | -0.488 | -0.444 |
EV/EBITDA |
-6.2 | -3.5 | -3.6 | -5.0 | -11.9 | -8.8 | -7.6 | -12.4 | -9.9 | -6.3 | -8.8 | ||
PEG |
-5.38 | -0.21 | -2.98 | -0.27 | -0.83 | 0.64 | -1.37 | 0.28 | 1.01 | 2.59 | -6.35 | 0.05 | -0.24 |
P/B |
0.5 | 0.5 | 1.4 | 1.8 | 2.9 | 2.3 | 6.9 | 3.5 | 2.4 | 3.6 | 5.5 | 6.0 | 6.1 |
P/CF |
-11.3 | -3.0 | -22.9 | -4.8 | -4.3 | -4.9 | -22.6 | 19.7 | -12.0 | -18.4 | -13.2 | -9.8 | -13.6 |
ROE % |
3.37 | -24.08 | -7.36 | -35.01 | -74.02 | -40.91 | -54.48 | -41.86 | -29.13 | -27.39 | -52.05 | -88.52 | -41.92 |
ROA % |
2.51 | -22.62 | -6.89 | -25.79 | -41.41 | -26.85 | -27.07 | -25.60 | -27.44 | -26.13 | -48.87 | -63.16 | -36.09 |
ROCE % |
-9.37 | -25.93 | -14.22 | -29.32 | -49.84 | -31.57 | -32.11 | -25.53 | -29.69 | -28.35 | -52.73 | -62.02 | -62.69 |
Current Ratio |
- | - | - | 8.9 | 6.3 | 6.8 | 3.9 | 8.6 | 11.7 | 22.4 | 17.4 | 8.2 | 9.7 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 5422.3 | -4817.2 | 1114.5 | 1051.1 | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | -5422.3 | 4817.2 | -1114.5 | -1051.1 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Oramed Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.22 | 0.04 | - | 0.08 | -0.03 | -0.08 | - | 0.18 | 0.27 | 0.27 | 0.31 | 0.21 | 0.12 | 0.2 | 0.3 | 0.44 | 0.1 | 0.23 | 0.15 | 0.69 | 0.23 | 0.15 | 0.25 | 0.68 | 0.3 | 0.25 | 0.18 | 0.59 | 0.15 | 0.18 | 0.2 | 0.5 | 0.15 | 0.2 | 0.21 | 0.48 | 0.15 | 0.21 | 0.19 | 0.45 | 0.18 | 0.19 | 0.14 | 0.49 | 0.17 | 0.14 | 0.14 | 0.34 | 0.09 | 0.01 | 0.01 | 0.01 | -0.01 | 0.01 |
EBITDA per Share |
- | -0.07 | - | - | - | -0.13 | - | -0.21 | -0.29 | -0.29 | -0.32 | -0.21 | -0.14 | -0.29 | -0.31 | -0.45 | -0.1 | -0.25 | -0.14 | -0.7 | -0.23 | -0.14 | -0.27 | -0.72 | -0.31 | -0.27 | -0.19 | -0.6 | -0.16 | -0.19 | -0.18 | 0.52 | 0.16 | 0.18 | 0.21 | -0.49 | -0.15 | -0.21 | -0.19 | 0.47 | 0.19 | -0.19 | -0.15 | -0.47 | -0.18 | -0.13 | -0.11 | -0.33 | -0.09 | -0.12 | -0.01 | -0.03 | -0.01 | -0.01 |
ROE % |
1.80 | -4.19 | -5.21 | -9.82 | -12.27 | -18.36 | -18.09 | -25.46 | -26.97 | -24.39 | -22.55 | -41.15 | -60.93 | -63.56 | -78.55 | -67.41 | 20.76 | 51.43 | 56.36 | 56.27 | -37.50 | -75.22 | -75.31 | -71.53 | -80.49 | -76.71 | -72.94 | -72.80 | -8.65 | 9.19 | 10.26 | 10.64 | -33.65 | -47.65 | -47.21 | -44.61 | -4.44 | 10.72 | 11.23 | 3.85 | -58.03 | -118.87 | -123.58 | -123.53 | -169.74 | -206.22 | -217.77 | -216.85 | -170.26 | -123.66 | -111.13 | -41.94 | -41.92 | -12.85 |
ROA % |
2.96 | -2.80 | -4.28 | -8.58 | -11.48 | -17.20 | -17.00 | -23.89 | -25.49 | -23.85 | -22.07 | -33.06 | -46.25 | -46.51 | -54.55 | -44.84 | 9.07 | 25.94 | 31.08 | 29.38 | -26.14 | -47.07 | -48.81 | -45.03 | -44.46 | -40.35 | -37.81 | -37.59 | -3.00 | 6.74 | 7.12 | 2.98 | -30.91 | -41.58 | -44.50 | -42.21 | -4.14 | 10.25 | 10.62 | 4.30 | -54.09 | -111.34 | -115.62 | -115.63 | -139.06 | -153.36 | -158.48 | -156.70 | -129.62 | -102.55 | -95.50 | -36.09 | -36.09 | -11.06 |
ROCE % |
-7.23 | -7.94 | -7.69 | -12.88 | -16.18 | -21.06 | -19.29 | -26.53 | -27.20 | -24.49 | -22.34 | -36.56 | -52.51 | -53.56 | -65.38 | -53.08 | -73.14 | -82.50 | -75.01 | -77.61 | -59.98 | -55.53 | -58.00 | -53.74 | -53.12 | -48.96 | -44.90 | -43.37 | -3.26 | 8.55 | 22.04 | 38.85 | 1.39 | -10.56 | -26.53 | -45.39 | -4.00 | 11.71 | 12.43 | 4.52 | -56.67 | -82.16 | -87.34 | -82.70 | -83.80 | -79.07 | -80.49 | -82.61 | -88.14 | -91.74 | -88.00 | -47.39 | -15.23 | -11.99 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.5 | 7.1 | - | 7.2 | 7.2 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1288.2 | - | - | 2682.8 | -1091.8 | - | 3388.0 | - | 662.7 | 662.7 | - | 344.3 | -5364.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1288.2 | - | - | -2682.8 | 1091.8 | - | -3388.0 | - | -662.7 | -662.7 | - | -344.3 | 5364.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency